Treatment with small interfering RNA affects the microRNA pathway and causes unspecific defects in zebrafish embryos

Xiao-Feng Zhao1, Anders Fjose, Natalia Larsen

  • 1Department of Molecular Biology, University of Bergen, Norway.

The FEBS Journal
|April 4, 2008
PubMed

Insights

Small interfering RNA (siRNA) can inhibit microRNA (miRNA) processing in zebrafish, causing developmental defects. Restoring miR-430 levels rescues these defects, suggesting siRNA impacts miRNA pathways.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are crucial post-transcriptional regulators processed by Drosha and Dicer.
  • Dicer is a key component of RNA-induced silencing complexes (RISCs).
  • miR-430 in zebrafish promotes maternal mRNA degradation during embryogenesis.

Purpose of the Study:

  • To investigate the effects of small interfering RNA (siRNA) on miRNA processing and embryonic development in zebrafish.
  • To determine if siRNA-induced developmental abnormalities are linked to miRNA pathway interference.

Main Methods:

  • Injection of one-cell-stage zebrafish embryos with siRNA.
  • Quantification of endogenous miRNA levels (including miR-430) post-siRNA injection.
  • Assessment of developmental outcomes in treated zebrafish embryos.
  • Rescue experiments involving coinjection of siRNA with preprocessed miR-430.

Main Results:

  • siRNA injection significantly reduced endogenous levels of processed miR-430 and other miRNAs.
  • siRNA treatment led to unspecific developmental defects in zebrafish embryos.
  • Coinjection with preprocessed miR-430 efficiently rescued the developmental abnormalities.
  • These findings suggest siRNA inhibits miR-430 processing and/or activity.

Conclusions:

  • The developmental defects observed in siRNA-treated zebrafish are likely due to the inhibition of miRNA processing and/or activity.
  • The study highlights potential cross-talk between siRNA and the miRNA pathway.
  • Results suggest that the miRNA pathway in mammals might be affected by siRNA under certain experimental or therapeutic conditions.